Yale Researchers Develop New Testing Criteria for Hereditary Stomach Cancer
Yale researchers have shown that individuals who carry a mutation in the CDH1 gene have a 30% to 40% risk of developing stomach cancer during their lifetime. Yet many people with the rare inherited condition remain unaware that they have it.
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities
In my opinion, one of the greatest advances in oncology has been the discovery of cancer genes that can provide information about hereditary cancer risk and guide cancer screening and treatment. Indeed, 5-15% of patients with cancer have inheritedopens in a new tab or window genetic mutations. Let's put this in context.Source: MedPage Today
Yale Program Treats Individuals at High Risk for Gastrointestinal and Pancreatic Cancers
Yale’s Digestive Health Center, a hub offering advanced medical and surgical treatments for individuals with gastrointestinal issues, recently opened the Gastrointestinal (GI) and Pancreatic Cancer Prevention Program at its North Haven location.
How Exercise Boosts Your Body’s Ability to Prevent Cancer
Forty-five minutes of intense exercise three times a week may reduce cancer risk in patients with Lynch syndrome, a genetic condition that can lead to cancer at a young age. “One thing is having the epidemiological correlation, but it’s another thing to know the biological basis,” Xavier Llor, MD, PhD, director of the GI Cancer Prevention Program at Yale Cancer Center and professor of medicine at Yale School of Medicine. (Llor was not involved in the study.)Source: WebMD
Drs. Veda Giri and Lajos Pusztai named Fellows of the American Society of Clinical Oncology
Veda Giri, MD, Chief of Clinical Cancer Genetics and Co-Director of the Early Onset Cancer Program at Smilow Cancer Hospital and Yale Cancer Center, and Lajos Pusztai, MD, DPhil, Professor of Medicine (Medical Oncology), have been named Fellows of the American Society of Clinical Oncology (FASCO).
Prioritizing Cancers in Younger Adults
Yale Cancer Center and Smilow Cancer Hospital’s Early Onset Cancer Program will focus on patients with cancer diagnosed between the ages of 18-49. The program has far-reaching goals to address their psychosocial needs, develop novel clinical care models, enhance clinical trials, expand research, and raise community awareness about early onset cancers.
Pancreatic Cancer Risk Lower if Cysts Remain Stable for Five Years
Low-risk branch duct intraductal papillary mucinous neoplasms (IPMN) are the most common precancerous form of mucinous pancreatic cysts and once identified require regular surveillance imaging. But consensus is still forming around how long that watchful period should last. In a new study, Yale Cancer Center researchers question the health benefit of extended surveillance for patients whose cyst has not changed size for at least five years and has no worrisome features.
Disease in twins: Do twins have the same health problems?
Dr Michael Murray, a geneticist at the Yale Cancer Centre, says that with a triplet birth and higher multiple births, you can have all identical, all fraternal, or both identical and fraternal, so the risk varies. He says there are two different categories of genetic cancer risk. "There's what we call monogenic (or single gene) genetic risk, which means that one out of your 20,000 genes can be broken in a way that predisposes you to genetic risk for cancer.Source: Reader's Digest